You can view 5 more pages before signing in

Exposure to progestogen-only injectable contraception in pregnancy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Seek expert advice.

The SPC for Depo-Provera states that infants born from accidental pregnancies that occur 1-2 months after injection may be at increased risk of low birth weight and neonatal death (1)

based on an observational study130 of Thai DMPA users in which the authors acknowledge the difficulties of adjusting for confounding variables such as differences in antenatal care, socioeconomic status, smoking and alcohol use among DMPA users and controls. Longer-term follow-up of the same group of children showed no evidence of any adverse effects on their growth or pubertal development
other observational data have not shown any adverse effects on physical, intellectual, sexual or social development of children exposed to DMPA in utero and followed to adolescence

NICE (2) recommend that if a pregnancy occurs while using progestogen-only injectable contraception women should be advised that there is no evidence of harm to the pregnancy or fetus

Reference:

FSRH (April 2019). Progestogen-only Injectable Contraception
NICE (September 2014). Long-acting reversible contraception (update).

Depo Provera

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

Exposure to progestogen-only injectable contraception in pregnancy

Related pages

Create an account to add page annotations